UNCY logo

Unicycive Therapeutics (UNCY)

Profile

Full Name

Unicycive Therapeutics, Inc.

Ticker Symbol

UNCY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 12, 2021

Indexes

Not included

Website

http://unicycive.com

Employees

22

Key Details

Price

$0.60(+0.67%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.56(+56.25% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.60
UNCY price is $0.60

30-Day Relative Volume

0.20
UNCY 30-day relative volume is 0.20

Price Performance

Price Most recent change

+0.67%
UNCY price was up +0.67% on Apr 16, 2025

Price YTD change

-24.69%
UNCY price is down -24.69% since January 1st

Price 1-year change

-46.61%
UNCY price is down -46.61% year-on-year

Price 3-year change

-44.63%
UNCY price is down -44.63% over the past 3 years

Price Range

Price All-time high

$8.73
UNCY price is currently -93.15% below its historical high of $8.73

Price 3-year low

$0.20
UNCY price is currently +196.04% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$71.58M
UNCY market capitalization is $71.58 million

Market cap 3-year change

+341.27%
UNCY market capitalization is up +341.27% over the past 3 years

Market cap All-time high

$90.39M
UNCY market capitalization is currently -20.81% below its historical high of $90.39 million

Market cap sector rank

43.5%
UNCY market capitalization is higher than 43.5% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+218.31%
UNCY shares outstanding is up +218.31% year-on-year

Shares Outstanding 3-Year Change

+696.94%
UNCY shares outstanding is up +696.94% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.79
UNCY beta is 0.79

200-day SMA

$0.52
UNCY price is currently +14.74% above its 200-day simple moving average

50-day SMA

$0.58
UNCY price is currently +3.82% above its 50-day simple moving average

RSI

53.82
UNCY 14-day relative strength index is 53.82

Volume

0.20
UNCY 30-day relative volume is 0.20

ATR

$0.06
UNCY average true range is $0.06

10-day Historical Volatility

124.83%
UNCY 10-day historical volatility is 124.83%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
UNCY annual revenue value is unknown

Revenue Analysts estimate

$20.53M
UNCY annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
UNCY annual revenue 1-year change is unknown

Revenue Sector rank

-
UNCY annual revenue is unknown

EPS

EPS

-$0.56
UNCY annual earnings per share is -$0.56

EPS Analysts estimate

-$0.17
UNCY annual earnings per share is currently +220.00% higher than the consensus analysts' forecast

EPS 1-year change

+56.25%
UNCY annual earnings per share is up +56.25% year-on-year

EPS Sector rank

66.78%
UNCY annual earnings per share is higher than 66.78% of companies in Healthcare sector

Profit

Gross profit

-
UNCY annual gross profit value is unknown

Gross margin

-
UNCY annual gross profit margin value is unknown

Operating profit

-$32.12M
UNCY annual operating income is -$32.12 million

Operating margin

-
UNCY annual operating profit margin value is unknown

Net income

-$36.73M
UNCY annual net profit is -$36.73 million

Net margin

-
UNCY annual net profit margin value is unknown

Expenses

Total expenses

$32.12M
UNCY annual total expenses is $32.12 million

Operating expenses

$32.12M
UNCY annual total operating expenses is $32.12 million

Cost of goods sold

-
UNCY annual cost of goods sold value is unknown

Selling, general & administrative expenses

$12.10M
UNCY annual SGA is $12.10 million

Depreciation and amortization

$428.00K
UNCY annual depreciation & amortization is $428.00 thousand

Interest expense

$71.00K
UNCY annual interest expense is $71.00 thousand

Income tax

-
UNCY annual income tax value is unknown

EBIT & EBITDA

EBIT

-$36.66M
UNCY annual earnings before interest & taxes is -$36.66 million

EBITDA

-$36.23M
UNCY annual EBITDA is -$36.23 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$31.67M
UNCY annual total assets is $31.67 million

Non current assets

$720.00K
UNCY annual long term assets is $720.00 thousand

Current assets

$30.95M
UNCY annual total current assets is $30.95 million

Cash and cash equivalents

$26.14M
UNCY annual cash & cash equivalents is $26.14 million

Accounts receivable

-
UNCY annual accounts receivable value is unknown

Inventory

-
UNCY annual inventory value is unknown

Liabilities

Total liabilities

$24.24M
UNCY annual total liabilities is $24.24 million

Long term liabilities

$117.00K
UNCY annual total long term liabilities is $117.00 thousand

Current liabilities

$24.12M
UNCY annual total current liabilities is $24.12 million

Accounts payable

$966.00K
UNCY annual accounts payable is $966.00 thousand

Debt

Total debt

$773.00K
UNCY annual total debt is $773.00 thousand

Total debt 1-year change

-4.69%
UNCY annual total debt is down -4.69% year-on-year

Long term debt

$117.00K
UNCY annual long term debt is $117.00 thousand

Short term debt

$656.00K
UNCY annual short term debt is $656.00 thousand

Equity & Capital

Shareholders equity

$7.43M
UNCY annual stockholders equity is $7.43 million

Book value

$7.43M
UNCY annual book value is $7.43 million

Retained earnings

-$101.27M
UNCY annual retained earnings is -$101.27 million

Working capital

$6.83M
UNCY annual working capital is $6.83 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$28.57M
UNCY annual cash flow from operations is -$28.57 million

Cash from operations 1-year change

-56.29%
UNCY annual cash flow from operations is down -56.29% year-on-year

Cash from investing

-$72.00K
UNCY annual cash flow from investing activities is -$72.00 thousand

Cash from investing 1-year change

-500%
UNCY annual cash flow from investing activities is down -500% year-on-year

Cash from financing

$45.09M
UNCY annual cash flow from financing activities is $45.09 million

Cash from financing 1-year change

+63.71%
UNCY annual cash flow from financing activities is up +63.71% year-on-year

CAPEX

CAPEX

-
UNCY annual capital expenditures value is unknown

CAPEX 1-year change

-
UNCY annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$28.65M
UNCY annual free cash flow is -$28.65 million

Free cash flow 1-year change

-56.58%
UNCY annual free cash flow is down -56.58% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
UNCY annual gross profit margin value is unknown

Operating margin

-
UNCY annual operating profit margin value is unknown

Net margin

-
UNCY annual net profit margin value is unknown

ROA & ROE

ROA

-115.98%
UNCY annual return on assets is -115.98%

ROE

-494.27%
UNCY annual return on equity is -494.27%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
UNCY price to earnings ratio value is unknown

PE ratio Sector rank

-
UNCY price to earnings ratio is unknown

PB Ratio

PB ratio

9.63
UNCY price to book ratio is 9.63

PB ratio Sector rank

92.18%
UNCY price to book ratio is higher than 92.18% of companies in Healthcare sector

PS Ratio

PS ratio

-
UNCY price to sales ratio value is unknown

PS ratio Sector rank

-
UNCY price to sales ratio is unknown

Enterprise value

Enterprise value

$46.21M
UNCY enterprise value is $46.21 million

Enterprise value Sector rank

40.53%
UNCY enterprise value is higher than 40.53% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.28
UNCY EV/EBITDA is -1.28

EV/EBITDA Sector rank

38.73%
UNCY EV/EBITDA is higher than 38.73% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.28
UNCY annual current ratio is 1.28

Quick ratio

-
UNCY annual quick ratio value is unknown

Leverage

Debt to equity

0.10
UNCY annual debt to equity ratio is 0.10

Interest coverage ratio

-516.31
UNCY annual interest coverage ratio is -516.31

Risk & Stability

Piotroski F-Score

-
UNCY piotroski f-score value is unknown

Altman Z-Score

-
UNCY altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 11, 25 HC Wainwright & Co.
Buy
Apr 1, 25 HC Wainwright & Co.
Buy
Jan 29, 25 HC Wainwright & Co.
Buy
Jan 8, 25 HC Wainwright & Co.
Buy
Nov 22, 24 Benchmark
Speculative Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 12, 24 HC Wainwright & Co.
Buy
Oct 9, 24 HC Wainwright & Co.
Buy
Sep 6, 24 Benchmark
Speculative Buy
Sep 3, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

GNTA logo
Genenta Science SpA (GNTA)
IGMS logo
IGM Biosciences (IGMS)
MNOV logo
MediciNova (MNOV)
CRBP logo
Corbus Pharmaceuticals Holdings (CRBP)
MLSS logo
Milestone Scientific (MLSS)
IFRX logo
InflaRx NV (IFRX)
ANL logo
Adlai Nortye American Depositary Shares (ANL)
VIGL logo
Vigil Neuroscience (VIGL)
TBIO logo
Telesis Bio (TBIO)
  • What is the ticker symbol for Unicycive Therapeutics?
  • Does Unicycive Therapeutics pay dividends?
  • What sector is Unicycive Therapeutics in?
  • What industry is Unicycive Therapeutics in?
  • What country is Unicycive Therapeutics based in?
  • When did Unicycive Therapeutics go public?
  • Is Unicycive Therapeutics in the S&P 500?
  • Is Unicycive Therapeutics in the NASDAQ 100?
  • Is Unicycive Therapeutics in the Dow Jones?
  • When was Unicycive Therapeutics's last earnings report?
  • When does Unicycive Therapeutics report earnings?
  • Should I buy Unicycive Therapeutics stock now?

What is the ticker symbol for Unicycive Therapeutics?

The ticker symbol for Unicycive Therapeutics is NASDAQ:UNCY

Does Unicycive Therapeutics pay dividends?

No, Unicycive Therapeutics does not pay dividends

What sector is Unicycive Therapeutics in?

Unicycive Therapeutics is in the Healthcare sector

What industry is Unicycive Therapeutics in?

Unicycive Therapeutics is in the Biotechnology industry

What country is Unicycive Therapeutics based in?

Unicycive Therapeutics is headquartered in United States

When did Unicycive Therapeutics go public?

Unicycive Therapeutics's initial public offering (IPO) was on July 12, 2021

Is Unicycive Therapeutics in the S&P 500?

No, Unicycive Therapeutics is not included in the S&P 500 index

Is Unicycive Therapeutics in the NASDAQ 100?

No, Unicycive Therapeutics is not included in the NASDAQ 100 index

Is Unicycive Therapeutics in the Dow Jones?

No, Unicycive Therapeutics is not included in the Dow Jones index

When was Unicycive Therapeutics's last earnings report?

Unicycive Therapeutics's most recent earnings report was on Mar 31, 2025

When does Unicycive Therapeutics report earnings?

The next expected earnings date for Unicycive Therapeutics is May 13, 2025

Should I buy Unicycive Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page